|
Active
Grants |
|
|
Grant
#: 1 R21
HL087-879-01 |
| |
Principal Investigator: |
Donna Parker, Sc.D |
|
Funding Source: |
NIH/NHLBI |
|
Duration of Grant: |
04/10/2007-03/31/2008 |
|
This
project proposes a one-year pilot study to explore the use of a novel biomarker
of nicotine metabolism, the ratio of trans-3’-hydroxycotinine to cotinine
(3-HC:C), as an estimate of nicotine exposure from tobacco during pregnancy. |
|
|
Grant
#: K07
CA106780-01A2
Colorectal Cancer Decision Aids in Primary Care |
| |
Principal Investigator: |
Joseph A.Diaz, MD |
|
Funding Source: |
NIH/NCI |
|
Duration of Grant: |
05/01/2006-04/30/2011 |
|
The primary
objective of the current proposal is to develop a survey instrument (in English
and Spanish) to evaluate the effectiveness of colorectal cancer decision aids
for patients considering screening. This objective will be achieved by: (1)
identifying patients’ beliefs and potential misconceptions about colorectal
cancer screening via focus groups; (2) developing an evidence-based instrument
to measure patients’ knowledge, judgments and level of decisional conflict
regarding screening; and (3) via a cross-sectional study of primary care
patients, validating the instrument and simultaneously assessing patients’
baseline levels of knowledge, judgments, and decisional conflict about
colorectal cancer screening. |
|
|
Grant
#: 1 K23
HD001472-05 Women
in Prison: Decreasing Unplanned Pregnancies & STD's |
| |
Principal Investigator: |
Jennifer G. Clarke, MD, MPH |
|
Funding Source: |
NIH/NICHD |
|
Duration of Grant: |
08/15/2001-12/31/2007 |
|
A career
development award with focus on obtaining an MPH, assessing the reproduction
health needs of women in prison. |
|
|
Grant
#: 1 K23
MH078779-02
Routine HIV Testing in Primary Care Practices - Project SEARCH |
| |
Principal Investigator: |
Emma M. Simmons, MD, MPH |
|
Funding Source: |
NIH/NIMH |
|
Duration of Grant: |
07/11/2006-06/30/2011 |
|
This
proposal seeks to develop and pilot test an intervention that will promote
routine HIV testing and evaluate its acceptance by primary care providers
(PCPs), office staff and patients in community health centers that serve
disadvantaged minority communities (Blacks and Latinos). |
|
|
Grant
#: 5 U65
PS124165-03
Routine HIV Testing in the Primary Care Setting. |
| |
Principal Investigator: |
Emma M. Simmons, MD, MPH |
|
Funding Source: |
CDC/OCOO/PGO |
|
Duration of Grant: |
07/1/2004-09/29/2007 |
|
Minority
HIV/AIDS Research Initiative – Project CHAT
The goal of this cooperative agreement is to gather data from underserved
minorities in the primary care setting on attitudes towards routine HIV testing. |
|
|
Grant
#: 3 R01
HL070804-04S2
Translating ATP III Cholesterol Management Guidelines / Minority Supplement |
| |
Principal Investigator: |
Charles B. Eaton, MD, MS |
|
Funding Source: |
NIH/NHLBI |
|
Duration of Grant: |
09/1/2005-08/31/2006 |
|
|
|
|
Grant
#: 5 R34
MH075013-03 |
| |
Principal Investigator: |
Caron Zlotnick, Ph.D / Donna Parker, Sc.D |
|
Funding Source: |
NIH/NIMH |
|
Duration of Grant: |
09/29/2005-06/30/2008 |
|
|
|
|
Grant
#: 1 R03
HG004158-01 |
| |
Principal Investigator: |
Robert Gramling, MD |
|
Funding Source: |
NIH/NHGRI |
|
Duration of Grant: |
: 01/01/2007-12/31/2008 |
|
|
|
|
Grant
#: NIH-NOI-WHI-3-2119
Vanguard Clinical Center for Clinical Trials
and Observational Study of the Women's Health Initiative; Women's
Health Initiative Satellite Center and Enhanced Recruitment |
| |
Principal Investigator: |
Annlouise R. Assaf, Ph.D. |
|
Co-Principal Investigator: |
Richard Carleton, M.D. (3/93 to 12/01), Charles
B. Eaton M.D., M.S. & Michele Cyr, M.D. (12/01-present). |
|
Funding Source: |
NIH, National Heart, Lung, and Blood Institute |
|
Duration of Grant: |
3/15/93 - 9/14/2010 |
|
Women's Health
Initiative Clinical Center (WHI) at MHRI is the largest of the 40 NHLBI-funded
WHI Clinical Centers. WHI, which is a fifteen-year landmark research study
of postmenopausal women and their health, is designed to look at the effects
of diet, hormone replacement therapy, and calcium and vitamin D on the
prevention of major diseases such as heart disease, breast and colorectal
cancer, and fractures from osteoporosis. In addition to the clinical trial
component of the WHI, there is also a large observational study component in
which postmenopausal women are followed from nine to twelve years to
ascertain predictors of disease. The WHI at MHRI is a collaborative effort
with a community coalition of over 200 agencies and investigators from
all of the Brown University affiliated hospitals and the University of
Rhode Island. Over 6,200 women were recruited to participate in the MHRI
center and its satellite center at Charleton Memorial Hospital in Massachusetts.
Average follow-up time is nine years.
Click here to learn more about WHI... |
|
|
Grant
#: NIH-NIAMS-02-03
Clinical Centers for the Osteoarthritis Initiative |
|
Principal Investigator: |
Charles B. Eaton, M.D., M.S. |
|
Co-Principal Investigators: |
Tim McAlindon M.D.; Faiza Estrup M.D., PhD |
|
Funding Source: |
NIH, National Institute of Arthritis and Musculoskeletal
and Skin Deseases |
|
Duration of Grant: |
7/02-6/09 |
|
This study will
implement a multi-center longitudinal prospective, population-based study
of knee osteoarthritis (OA) in order to develop public domain research
resources. This resource will help researchers discover and evaluate biomarkers
for the onset and progressions of this disease. |
|
| Grant
#: 1RO1HL78804
Translating ATP III Cholesterol Management
Guidelines Into Primary Care Practice |
|
Principal Investigator: |
Charles B. Eaton M.D., M.S. |
|
Co-Principal Investigator: |
Donna Parker Sc. D. |
|
Co-Investigators: |
Jeff Borkan M.D., Ph.D.; Roberta Goldman Ph.D.;
Kim Gans Ph.D. |
|
Funding Source: |
NIH, National Heart, Lung, and Blood Institute |
|
Duration of Grant: |
7/02-12/07 |
|
This project will
demonstrate and evaluate the translation of the ATP III Cholesterol management
guidelines into primary care practice. During phase 1, a needs assessment
will evaluate barriers and facilitators to implementation of ATP III guidelines
into clinical practice through focus groups of primary care patients and
providers. During phase 2, a block, randomized designed cluster trial will
be performed with one year of intervention within primary care practices
(24 practices/48 providers) throughout the state of Rhode Island and Southeastern
New England to test the effectiveness of the materials developed in phase
I to improve physician performance around ATP III guideline implementation
and to improve clinically relevant outcomes, the percentage of patients
with LDL-cholesterol at their ATP III goal. |
|
K08 Mentored Clinical Science Development Award
Psychological and Genetic Determinants of Smoking Cessation |
| |
Principal
Investigator: |
Sean David, M.D.,
S.M., D.Phil. |
| |
Funding Source: |
National Institute
on Drug Abuse |
| |
Duration of Grant: |
9/27/02-8/31/07 |
| |
This study will
evaluate the role of genetic factors in response to standard smoking cessation
treatment; test whether bupropion interacts with the genotype to influence
multiple behavioral mediating variables that place smokers at increased risk for
relapse; test the hypotheses that bupropion diminshes the reinforcing properties
of smoking and genetically predisposed smokers derive greater benefit from
bupropion than genetically protected smokers; investigate the interaction
between genotype and cue reactivity among genetically predisposed smokers and
genetically protected smokers; and evaluate the impact of additional
dopaminergic candidate gene polymorphisms on treatment response to bupropion. |
| |
|
| |
|
|
PAST PROJECTS |
| |
| The Pawtucket
Heart Health Program (PHHP) |
|
Co-Principal Investigator: |
Annlouise R. Assaf, Ph.D. |
|
Funding Source: |
NIH, National Heart, Lung, and Blood Institute |
|
PHHP was one of
the three large NHLBI-funded community-level CVD primary prevention studies.
PHHP, through partnerships with over 500 local organizations, facilitated
extensive programming in dietary change, cholesterol control, blood pressure
control, smoking cessation, weight control and physical activity. Over
40,000 individual adults participated in PHHP educational programs and
over 15,000 participated in random sample household surveys in Pawtucket
and our comparison city as part of the evaluation of PHHP. PHHP used extensive
formative and process evaluation procedures to develop and evaluate many
different types of behavior change programs. Both serial cross-sectional
and cohort household surveys were performed as was morbidity and mortality
surveillance. |
|
|
Grant #: TS 262-13/14
Psychosocial Issues in Cancer Prevention for
Hispanics |
|
Principal Investigator: |
Roberta Goldman, Ph.D. |
|
Funding Source: |
Center for Disease Control Association of Teachers
of Preventive Medicine |
|
Duration of Grant: |
10/01/97-9/30/01 |
|
Focuses on psychosocial
issues of cancer among Hispanics in order to identify barriers to cancer
screening and prevention methods. |
|
| Grant #:HL47624
Minimal Contact Education for Cholesterol Change |
|
Principal Investigator: |
Thomas M. Lasater, Ph.D. |
|
Co-Principal Investigator: |
Annlouise R. Assaf Ph.D. |
|
Funding Source: |
NIH, National Heart, Lung, and Blood Institute |
|
Duration of Grant: |
1992-1997 |
|
| Grant #:HL48250
Worksites, Occupational Nurses and Cholesterol
Change |
|
Principal Investigator: |
Thomas M. Lasater, Ph.D. |
|
Co-Investigator: |
Annlouise R. Assaf, Ph.D. |
|
Funding Source: |
NIH, National Heart, Lung, and Blood Institute |
|
Duration of Grant: |
1992-1995 |
|
| Reach Out:
Physicians' Initiative to Expand Care to Underserved Americans |
|
Principal Investigator & Program Director: |
H. Denman Scott, M.D., M.P.H. |
|
Funding Source: |
Robert Wood Johnson Foundation |
|
Duration of Grant: |
3/93-7/99 |
|
| Grant #:ACHPR290-98-0027
A Computerized Decision Support System for
Evidence-Based Medicine: HealthMetric |
|
Principal Investigator: |
David Ahern, Ph.D. |
|
Co-Principal Investigators: |
Charles B. Eaton, M.D., M.S.; Roy Poses M.D.;
H. Denman Scott M.D., M.P.H. |
|
Funding Source: |
Agency of Healthcare Policy and Research |
|
Duration of Grant: |
9/1998-4/1999 |
|
Members of the
project team have worked together to create a prototype of the web-based
decision support tool for CHF, HeartMetric during a phase I SBIR grant
No. 290-98-0027 funded by Agency of Healthcare Policy and Research. The
process that members of the project team went through to develop this tool
consisted of having a modified Delphi consensus panel of investigators
and consultant opinion leaders to better understand the issues and problems
inherent in developing a decision support tool that would support evidence-based
medicine using CHF as a model. This information informed our development
of the decision support tool. Four steps were required to develop the CHF
decision support tool. These included:
-
reverse engineering the evidence-based CHF guidelines to produce Messages
to be delivered to physicians regarding diagnosis and management;
-
linking these messages to appropriate patients by defining appropriate
clinical variables and developing programmed decision rules;
-
developing a prototype graphical user interface for data collection and
to serve a template for an electronic medical record;
-
incorporating a feedback mechanism for continuous quality improvement of
the decision support tool.
|
|
| Rhode Island
Atherosclerosis Surveillance System |
|
Principal Investigator: |
Charles B. Eaton, M.D., M.S. |
|
Funding Source: |
Merck & Co. |
|
Secondary Cardiovascular
Disease Project. Interventions consisted of the following:
-
changing the in-hospital critical pathway to include holding admission
blood for lipid profile measurements, standardized order for fasting lipids
to be performed;
-
Lipid disorders management pocket guidelines based upon ATP II guidelines
and physical activity guidelines were sent to each office practice;
-
periodic reminder phone calls and letters were sent to patients, primary
care physicians and consulting cardiologists over 1 year of follow-up.
|
|
| Faculty
Development in General Internal Medicine |
|
Principal Investigator: |
Anne W. Moulton, M.D. |
|
Investigator: |
Roy Poses, M.D. |
|
Funding Source: |
HRSA |
|
Duration of Grant: |
1995-1999 |
|
| Residency
Training in Primary Care Medicine |
|
Principal Investigator: |
Michele Cyr, M.D. |
|
Investigator: |
Roy Poses, M.D. |
|
Funding Source: |
HRSA |
|
Duration of Grant: |
1996-1999 |
|
| An Evaluation
of Practice Patterns: Lipid Lowering Agents for Coronary Heart Disease
and ACE Inhibitors for Congestive Heart Failure |
|
Principal Investigator: |
Roy Poses, M.D. |
|
Funding Source: |
Merck & Co. Human Health Division |
|
Duration of Grant: |
1997-1999 |
|
| Grant #:AG-11624
Do Good Nursing Homes Achieve Good Outcomes? |
|
Principal Investigator: |
Vincent Mor, Ph.D. |
|
Site Principal Investigator: |
Roy Poses, M.D. |
|
Funding Source: |
NIH, National Institute on Aging |
|
Duration of Grant: |
2000-2001 |
|
| Biochemical
Validation of Smoking Status Assessed with the Nicotine Metabolite Test
Strip |
|
Principal Investigator: |
Donna Parker, Sc.D. |
|
Funding Source: |
Rhode Island Foundation |
|
Duration of Grant: |
1998 |
|
| Project
to Evaluate Practice Patterns: Antibiotic Prescribing |
|
Principal Investigator: |
Roy Poses, M.D. |
|
Funding Source: |
Rockefeller Brothers Fund |
|
Duration of Grant: |
2000-2002 |
|
|
|
|
R13 Primary Care
Genetics Cancer Prevention Conference.
|
| |
Principal
Investigator: |
Sean David, M.D.,
S.M |
| |
Funding Source: |
National Cancer
Institute and National
Human Genome Research Institute |
| |
Duration of Grant: |
04/10/03 (one
time) |
| |
This grant funded a Transatlantic videoconference
with the Department of Primary Health Care at the University of
Oxford to promote and translate evidence-based genetic medicine in primary care.
|
|
|
Volunteers
in Healthcare |
|
Principal Investigator: |
H. Denman Scott M.D., MPH |
|
Funding Source: |
Robert Wood Johnson Foundation |
|
Duration of Grant: |
7/97-5/04 |
|
Program's goal
is to increase the capacity of private physicians and other medical volunteers
to provide medical care to indigent populations. The program offers technical
and consultative resources to assist volunteers developing programs to
provide medical care to the uninsured and underserved in their communities.
http://www.volunteersinhealthcare.org/ |
|
|
Grant #: NIH-HL-97-011
Nutrition Academic Award - Linking Resources
for Brown Medical Nutrition Education |
|
Principal Investigator: |
Charles B. Eaton, M.D., M.S. |
|
Co-Principal Investigator: |
Kim Gans, Ph.D. |
|
Funding Source: |
NIH, National Heart, Lung, and Bloods Institute |
|
Duration of Grant: |
9/30/98-9/29/03 |
|
This 5-year NHLBI
award focuses on improving medical student, resident and practicing primary
care physicianís knowledge and skills regarding nutritional assessment
and counseling with particular emphasis on the prevention and treatment
cardiovascular disease and diabetes mellitus. Tools developed include WAVE
pocket card, Rapid Eating and Activity for Patients, ATP III guideline
cards, CD-ROM.
http://www.brown.edu/nutrition/ |
|
|
Grant #: 5D12HP 00121-02
Academic Administrative Units in Primary Care |
|
Principal Investigator: |
Charles B. Eaton M.D., M.S. |
|
Co-Investigator: |
Roberta Goldman Ph.D. |
|
Funding Source: |
HRSA, Bureau of Health Professions |
|
Duration of Grant: |
2001-2004 |
|
This grant is
focused on restructuring the research division in the Department of Family
Medicine to align itself with the Center for Primary Care and Prevention
and develop a critical mass of primary care researchers. The grant focuses
developing a Best Practices Technology Test Center working in conjunction
with Abacus Technologies and the Family Medicine teaching practice linking
electronic medical records to decision support tools and developing a practice
based research network in conjunction with the Rhode Island Academy of
Family Physicans. |
|
Generalist
Physician Faculty Scholars Program
Enhancing the State of the Art of Smoking
Cessation in Primary Care through Pharmacogenetics |
|
Principal Investigator: |
Sean David, M.D., S.M. |
|
Mentors: |
Charles B. Eaton, M.D., M.S.; Raymond Niaura,
Ph.D.; Kay Dickersin, Ph.D.; Kathleen Merikangas, Ph.D. |
|
Funding Source: |
Robert Wood Johnson Foundation |
|
Duration of Grant: |
7/01/02-6/30/06 |
|
This program will
involve genotyping approximately 2000 patients enrolled in tobacco use
studies at Brown University and Oxford University. This research will explore
the translational question of how specific genetic factors influence lifetime
smoking behavior and how genes, treatment with the nicotine patch and behavioral
variables interact to affect smoking cessation. |
|
|
AAFP
Advanced Research Training Award |
|
Principal Investigator: |
Sean David M.D., S.M. |
|
Mentors: |
Charles B. Eaton, M.D., M.S.; Larry Green, M.D. |
|
Funding Source: |
American Adademy of Family Physicians |
|
Duration of Grant: |
12/01-11/03 |
|
Dr. David is a
recipient of a competitive academic training award from the American Academy
of Family Physicians to support research exploring the genetic basis for
smoking cessation and to further develop a translational, transdisciplinary
tobacco use genetics research infrastructure that harnesses existing resources
at Brown University and forges a collaborative primary care genetics partnership
with the University of Oxford. |
|
| Ya
No Fumo!: An Innovative Smoking Cessation Intervention for Latino/Hispanic
Patients in Pawtucket and Central Falls, Rhode Island |
|
Principal Investigator: |
Sean David, M.D., S.M. |
|
Co-Principal Investigator: |
Marcia Smith, Ph.D. |
|
Funding Source: |
Rhode Island Department of Health |
|
Duration of Grant: |
2/01/02-6/30/03 |
|
A one-year, renewable
grant from the Rhode Island Department of Health for "Ya no Fumo!", a public-private
partnership that addresses major health disparities in smoking among the
Latino/Hispanic population in Pawtucket and Central Falls, Rhode Island. |
|
|
Cancer Research UK Laboratory Consumables Grant |
|
Principal Investigator: |
Sean David, M.D., S.M. |
|
Funding Source: |
Wellcome Trust Centre for Human Genetics |
|
Duration of Grant: |
01/02-1/31/04 |
|
This grant
funds laboratory consumables for cancer prevention research examining genetic
determinants of tobacco use to carry out genotyping in the Cancer Research UK
Genotyping Centre at the Wellcome Trust Centre for Human Genetics. |
|
|
Grant #:
NIH 5-PO1-CA75308-01A2
Cancer Control in Multiethnic, Working Class
Populations |
|
Principal Investigator: |
G. Sorensen |
|
Co-Investigator (Sub-contract): |
Roberta Goldman Ph.D. |
|
Funding Source: |
NIH |
|
Duration of Grant: |
5/01/99-1/31/03 |
|
This
program project tests a cancer prevention intervention for multiethnic,
working-class populations through small businesses and health centers. A cancer
prevention policy model will be developed. |
|
|
Grant
#: NCI 1 R25 CA82320-01
Communication Skills for Male Cancer Screening |
|
Principal Investigator: |
Catherine Dube Ed.D. |
|
Co-Investigator: |
Roberta Goldman, Ph.D. |
|
Funding Source: |
NIH, National Cancer Institute |
|
Duration of Grant: |
7/01/99-6/30/04 |
|
The purpose of
this grant is to design, develop, implement, evaluate and disseminate a
medical school curriculum focusing on communication skills key to effective
cancer prevention and early detection of prostate, testicular and colorectal
cancer among male patients. The curriculum will be fully implemented at
two pilot sites, and 8 additional medical schools. A version of the completed
curriculum for nurse practitioner and physician assistant training will
be provided via the world-wide-web. |
|
| Grant #:1D16HP00066
Predoctoral Education in Family Medicine |
|
Principal Investigator: |
Julie Taylor M.D., M.S. |
|
Co-Principal Investigator: |
Charles B. Eaton M.D., M.S. |
|
Funding Source: |
HRSA, Bureau of Health Professions |
|
Duration of Grant: |
7/01/01-6/30/04 |
|
To develop, implement
and evaluate three teaching modules focusing on health disparities in cardiovascular
disease, cancer and diabetes mellitus and 3 modules on cross-cultural medicine
in medical school clerkship in family medicine. |
|
|
Grant
#: NCIC CTG MAP.2.
A Randomized Study of the Effect of Exemestane
(Aromasin ®) vs Placebo on Breast Density in Postmenopausal Women at
Increased Risk for Development of Breast Cancer - Sponsored by Clinical
Trials Group - National Cancer Institute of Canada |
|
Principal Investigator (Sub Contract): |
Annlouise R. Assaf Ph.D. |
|
Funding Source: |
Pharmacia Corporation |
|
Duration of Grant: |
2002-2005 |
|
This trial will
determine whether post-menopausal women at increased risk of breast cancer
by the nature of their breast density will decrease breast density on the
experimental drug. |
|
| Grant #:2R01
CA 77290-03
Benign Breast Disease Add-On Study to the Women's
Health Initiative |
|
Principal Investigator (Sub-Contract): |
Annlouise R. Assaf , Ph.D. |
|
Funding Source: |
NIH |
|
Duration of Grant: |
2001-present |
|
The purpose of
this study is to determine if the adoption of a low-fat dietary pattern,
supplementation with calcium/vitamin D, and whether using hormone replacement
therapy will change the risk of benign breast disease. |
|
|
AAFP
Advanced Research Training Award |
|
Principal Investigator: |
Sean David M.D., S.M. |
|
Mentors: |
Charles B. Eaton, M.D., M.S.; Larry Green, M.D. |
|
Funding Source: |
American Adademy of Family Physicians |
|
Duration of Grant: |
12/01-11/03 |
|
Dr. David is a
recipient of a competitive academic training award from the American Academy
of Family Physicians to support research exploring the genetic basis for
smoking cessation and to further develop a translational, transdisciplinary
tobacco use genetics research infrastructure that harnesses existing resources
at Brown University and forges a collaborative primary care genetics partnership
with the University of Oxford. |